When Lukas Wartman, a researcher at Washington University, developed leukemia, his colleagues sequenced his cancer genome. The result was a totally unexpectedtreatment. Heidi L. Rehm, HMS assistant professor of pathology at Brigham and Women’s Hospital, is quoted.
